Skip to content Skip to footer
i4

MadeAi™ Honored as a Winner in the 2026 Artificial Intelligence Excellence Awards

Achievement recognizes organizations, products, teams, and individuals delivering measurable results through artificial intelligence CAMBRIDGE, April 9, 2026—MadeAi, Inc. (MadeAi) today announced it has been named a winner in the 2026 Artificial Intelligence Excellence Awards, in the Generative AI category supporting life sciences. Presented by the Business Intelligence Group, the award recognizes organizations, products, teams, and…

Read More

MadeAi

MadeAi™ Unveils New Capabilities for GVD and JCA Reporting, Setting a New Benchmark for Life Sciences GenAI-Enabled Evidence Synthesis and Reporting

GLASGOW, SCOTLAND and CAMBRIDGE, MA, USA, November 10, 2025—At ISPOR Europe 2025 today, MadeAi™, the GenAI-powered evidence synthesis and report generation platform for life sciences, announced the launch of new capabilities designed to streamline and accelerate global value dossier (GVD) and Joint Clinical Assessment (JCA) submissions. With these advancements, MadeAi delivers the most comprehensive, AI-native…

Read More

Stevie Award

CapeStart MadeAi™ GenAI Platform Wins a Stevie® Award in 2025 International Business Awards® for the Second Year in a Row

Newest version of MadeAi™ for content synthesis hailed by judges as “a significant leap in applying Generative AI to the life sciences”   Cambridge, MA, August 25, 2025—CapeStart, an AI solutions and services firm, announced that its CapeStart MadeAi™ GenAI Platform for Life Sciences Content Synthesis was a winner of a Stevie® Award in The…

Read More